Delisting riskPopularity #4,581
GELS · NASDAQ · Drug Manufacturers - Specialty & Generic

Gelteq (GELS)

Customizable ingestible gels for partner-branded health and animal-health products.

$0.5751
After hours−0.02 (−3.39%)
At close$0.5953(+4.24%)

13F · 13D/G · Form 4

Insiders16.29%1.50M shares
3 holders · as of Mar 18, 2026
Other83.71%7.69M shares
remainder

9.18M company shares as of Sep 2, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Nathan J. GivoniInsiderofficer: Chief Executive Officer
7.16%657,087filed Mar 18, 2026
Bradley Glenn KarpInsiderofficer: Head of Sales and Marketing
5.45%500,000filed Mar 18, 2026
Simon H. SzewachInsiderdirector
3.68%338,197filed Mar 18, 2026

13F

No 13F holders on record.

13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Form 4

Latest trades

Nothing filed in the last 12 months.

House and Senate disclosures

Not reported.